Status:
COMPLETED
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
Brief Summary
A non-interventional study to explore actual asthma control status in real-life environment and to observe the efficacy after stepped-up to Symbicort SMART or various identical regimens. The study wi...
Eligibility Criteria
Inclusion
- Asthma patient who was partly controlled or uncontrolled by previous controllers of ICS only, or low dose ICS plus either LABA, leukotriene modifier or theophylline; or ICS- naïve with severe and persist symptom based on physician's judgment
- According to GINA guideline, who need to step up the controller medications, and ICS/LABA to be prescribed based on physician's discretion
Exclusion
- Patients aged not within limitation refer to label information of various product prescribed
- Patients who have taken oral corticosteroids within 4 weeks prior to enrollment
- Patients with contraindications to prescribed medication
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
842 Patients enrolled
Trial Details
Trial ID
NCT00784953
Start Date
October 1 2008
End Date
May 1 2011
Last Update
November 10 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Changhua, Taiwan
2
Research Site
Kaohsiung City, Taiwan
3
Research Site
Keelung, Taiwan
4
Research Site
Taichung, Taiwan